Skip to content

A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer in Select Procedures

A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer and Generator G11 in Upper Gastrointestinal, Lower Gastrointestinal, and Gynecological Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04763421
Enrollment
145
Registered
2021-02-21
Start date
2021-04-22
Completion date
2023-09-29
Last updated
2024-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper GI; Lower GI; Gynecological

Brief summary

This prospective, single-arm, multi-center study will collect clinical data in a post-market setting by procedure group (upper gastrointestinal \[GI\], lower GI, and gynecological). Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ENSEAL X1 Curved Jaw and Generator G11 instructions for use.

Detailed description

The primary objective of this study is to demonstrate the acceptable performance and safety of the ENSEAL X1 Curved Jaw and Generator G11 devices when used per the instructions for use.

Interventions

DEVICEENSEAL X1 Curved Jaw

ENSEAL X1 Curved Jaw is used for vessel transection according to instructions for use.

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Primary laparoscopic or open procedure (upper gastrointestinal, lower gastrointestinal, or gynecological) where at least one vessel is planned to be transected by the ENSEAL X1 Curved Jaw device per the instructions for use; 2. Willingness to give consent and comply with all study-related evaluations and visit schedule; and 3. At least 18 years of age.

Exclusion criteria

1. Physical or psychological condition which would impair study participation; or 2. Enrollment in a concurrent interventional clinical study that could impact the study endpoints.

Design outcomes

Primary

MeasureTime frameDescription
Number of Vessels With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading ScaleOn the day of transection (Day 0)Number of vessels with \<= Grade 3 hemostasis based on hemostasis grading scale were reported. A 4-point grading scale was used to assess hemostasis in blood vessels. Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, monopolar device and/or touch-ups with ENSEAL X1; or Grade 4: significant bleeding (example, pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or use of additional hemostatic measures (example, hemoclips, staples, sutures, fibrin sealants, other advanced energy products).
Number of Participants With Device-related Adverse Events (AEs)From Day 0 up to post-procedure follow up visit (up to 28 days)Number of participants with device-related AEs were reported. Device-related AEs were those AEs identified as having a relationship of possibly, probably, or causally with the study devices.

Secondary

MeasureTime frameDescription
Number of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with tissues bundles division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues bundles by ENSEAL X1.
Number of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with tissues grasping using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues grasping by ENSEAL X1.
Number of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with tissues cutting using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues cutting by ENSEAL X1.
Number of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with adhesion removal or division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for adhesion removal or division by ENSEAL X1.
Number of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading ScaleOn the day of transection (Day 0)Number of vessels with hemostasis (Grade 1 to 4) based on hemostasis grading scale were reported. A 4-point grading scale was used to assess hemostasis in blood vessels. Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, monopolar device and/or touch-ups with ENSEAL X1; or Grade 4: significant bleeding (example, pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or use of additional hemostatic measures (example, hemoclips, staples, sutures, fibrin sealants, other advanced energy products).
Percentage of Grade 4 Vessel Transections Requiring Hemostasis MeasuresOn the day of transection (Day 0)Percentage of Grade 4 vessel transections requiring hemostasis measures were planned to be reported. Data was not collected and analyzed for this outcome measure because there were no hemostatic grade 4 vessel transections.
Number of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with tissues dissection using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues dissection by ENSEAL X1.
Number of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreOn the day of transection (Day 0)Number of participants with lymphatics bundles division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for lymphatic bundles by ENSEAL X1.

Countries

Italy, United Kingdom, United States

Participant flow

Participants by arm

ArmCount
ENSEAL X1 Curved Jaw
All participants were treated with ENSEAL X1 curved jaw device for transection of at least one vessel during laparoscopic or open procedure (upper gastrointestinal \[GI\], lower GI, or gynecological).
145
Total145

Baseline characteristics

CharacteristicENSEAL X1 Curved Jaw
Age, Continuous55.28 Years
STANDARD_DEVIATION 15.904
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
135 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
133 Participants
Sex: Female, Male
Female
101 Participants
Sex: Female, Male
Male
44 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 145
other
Total, other adverse events
58 / 145
serious
Total, serious adverse events
10 / 145

Outcome results

Primary

Number of Participants With Device-related Adverse Events (AEs)

Number of participants with device-related AEs were reported. Device-related AEs were those AEs identified as having a relationship of possibly, probably, or causally with the study devices.

Time frame: From Day 0 up to post-procedure follow up visit (up to 28 days)

Population: The Safety Analysis Set (SAS) included all participants who signed informed consent and for whom the ENSEAL X1 device was utilized during the surgical procedure.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Device-related Adverse Events (AEs)2 Participants
Primary

Number of Vessels With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading Scale

Number of vessels with \<= Grade 3 hemostasis based on hemostasis grading scale were reported. A 4-point grading scale was used to assess hemostasis in blood vessels. Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, monopolar device and/or touch-ups with ENSEAL X1; or Grade 4: significant bleeding (example, pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or use of additional hemostatic measures (example, hemoclips, staples, sutures, fibrin sealants, other advanced energy products).

Time frame: On the day of transection (Day 0)

Population: Full Analysis Set (FAS) included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, the number of vessels transected analyzed included all vessels that were transected and analyzed for this outcome measure.

ArmMeasureValue (COUNT_OF_UNITS)
ENSEAL X1 Curved JawNumber of Vessels With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading Scale279 Vessels transected
Secondary

Number of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with adhesion removal or division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for adhesion removal or division by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied1 Participants
ENSEAL X1 Curved JawNumber of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied27 Participants
ENSEAL X1 Curved JawNumber of Participants With Adhesion Removal or Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied21 Participants
Secondary

Number of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with lymphatics bundles division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for lymphatic bundles by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied1 Participants
ENSEAL X1 Curved JawNumber of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied18 Participants
ENSEAL X1 Curved JawNumber of Participants With Lymphatics Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied8 Participants
Secondary

Number of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with tissues bundles division using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues bundles by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied1 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied26 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Bundles Division Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied28 Participants
Secondary

Number of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with tissues cutting using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues cutting by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied1 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied1 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied3 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied38 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Cutting Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied44 Participants
Secondary

Number of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with tissues dissection using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues dissection by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied3 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied59 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Dissection Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied45 Participants
Secondary

Number of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale Score

Number of participants with tissues grasping using ENSEAL X1 device as assessed by Surgeon Satisfaction scale score were reported. Surgeon satisfaction scale score is a 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) where surgeon rated the use of the device for tissues grasping by ENSEAL X1.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ENSEAL X1 Curved JawNumber of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Dissatisfied0 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreDissatisfied4 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreNeither Satisfied or Dissatisfied9 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreSatisfied31 Participants
ENSEAL X1 Curved JawNumber of Participants With Tissues Grasping Using ENSEAL X1 Device as Assessed by Surgeon Satisfaction Scale ScoreVery Satisfied23 Participants
Secondary

Number of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading Scale

Number of vessels with hemostasis (Grade 1 to 4) based on hemostasis grading scale were reported. A 4-point grading scale was used to assess hemostasis in blood vessels. Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, monopolar device and/or touch-ups with ENSEAL X1; or Grade 4: significant bleeding (example, pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or use of additional hemostatic measures (example, hemoclips, staples, sutures, fibrin sealants, other advanced energy products).

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure. Here, the number of vessels transected analyzed included all vessels that were transected and analyzed for this outcome measure.

ArmMeasureGroupValue (COUNT_OF_UNITS)
ENSEAL X1 Curved JawNumber of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading ScaleGrade 1258 vessels transected
ENSEAL X1 Curved JawNumber of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading ScaleGrade 212 vessels transected
ENSEAL X1 Curved JawNumber of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading ScaleGrade 39 vessels transected
ENSEAL X1 Curved JawNumber of Vessels With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading ScaleGrade 40 vessels transected
Secondary

Percentage of Grade 4 Vessel Transections Requiring Hemostasis Measures

Percentage of Grade 4 vessel transections requiring hemostasis measures were planned to be reported. Data was not collected and analyzed for this outcome measure because there were no hemostatic grade 4 vessel transections.

Time frame: On the day of transection (Day 0)

Population: FAS included participants for whom the ENSEAL X1 device was utilized during the surgical procedure.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026